Access our exclusive content

Get our newsletter with exclusive

Sectors
Mining Energy Biotech Technology Small Caps
Opinion
The 420 Report The Green Keeper Trev's Stock Tips Buy and Cell Ctrl Alt Del Q&A Startups Market Wrap
Features
Property
Investor 101
Podcasts
Stock of the Week
Trifecta

Sectors
Mining Energy Biotech Technology Small Caps
Opinion
The 420 Report The Green Keeper Trev's Stock Tips Buy and Cell Ctrl Alt Del Q&A Startups Market Wrap
Features
Property
Investor 101
Podcasts
Stock of the Week
Trifecta

Keep me posted menu

Get our newsletter with exclusive

oncology

Imugene gains guidance for KEY-Vaxx Immunotherapy development

Imugene onboards renowned cancer scientist Michael Caligiuri

January 7th 2019

Imugene onboards renowned cancer scientist Michael Caligiuri

Connect with us

ASX Junior’s Under-Drilled Cuban Oil Asset Puts it in Multi-Billion Barrel Company

Get our newsletter with an exclusive article straight to your inbox

Get our newsletter sent straight to your inbox

© 2019 Finfeed.com. All Rights Reserved.

customer notice
privacy policy
financial services guide
disclosure policy
social media influencer policy
contact

The information in this website is general information only. Any advice is general advice only. Your personal objectives, financial situation or needs have not been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice. S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877).